Mark Genovese: Crohn’s disease is a chronic, inflammatory bowel disease associated with progressive bowel damage, disability, ...

Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...

Ulcerative colitis (UC) symptoms may include abdominal pain, cramping, and diarrhea. People can experience periods of remission followed by flare-ups, which can lead to treatment changes.

cohorts in its ongoing Phase 1a/b study of PALI-2108 for the treatment of Ulcerative Colitis (UC). Preliminary data from the SAD portion of the study, which evaluated doses ranging from 15 mg to 450 ...

Over 80% of patients maintained endoscopic response after two years of continuous Omvoh treatment in ongoing studies ...

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Louise Thompson has opened up about her future health procedures on her podcast, He Said She Said. The Lucky author and Made ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

Many with Crohn’s disease or ulcerative colitis sacrifice essential purchases like food and clothing for healthcare, survey ...

(RTTNews) - Palisade Bio, Inc. (PALI), Thursday announced a preliminary data from five planned Single Ascending Dose cohorts, showing that PALI-2018 was well-tolerated among doses ranging from 15 mg ...

Inflammatory Bowel Disease (IBD) is a term for chronic inflammatory conditions affecting the digestive tract, primarily Crohn ...